Labeling may differ between generic, brand-name products

被引:2
|
作者
Traynor, K
机构
关键词
D O I
10.1093/ajhp/59.10.912
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:912 / +
页数:2
相关论文
共 50 条
  • [41] Converting patients from brand-name clozapine to generic clozapine
    Sajbel, TA
    Carter, GW
    Wiley, RB
    [J]. ANNALS OF PHARMACOTHERAPY, 2001, 35 (03) : 281 - 284
  • [42] Generic versus brand-name cardiovascular drugs: a remarkable update
    Flacco, Maria Elena
    Fragassi, Giorgia
    Manzoli, Lamberto
    [J]. EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2015, 12 (04)
  • [43] Generic versus brand-name drugs used in cardiovascular diseases
    Lamberto Manzoli
    Maria Elena Flacco
    Stefania Boccia
    Elvira D’Andrea
    Nikola Panic
    Carolina Marzuillo
    Roberta Siliquini
    Walter Ricciardi
    Paolo Villari
    John P. A. Ioannidis
    [J]. European Journal of Epidemiology, 2016, 31 : 351 - 368
  • [44] GENERIC AND ALTERNATIVE BRAND-NAME PHARMACEUTICAL EQUIVALENTS - SELECT WITH CAUTION
    HENDELES, L
    HOCHHAUS, G
    KAZEROUNIAN, S
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (02): : 323 - 329
  • [45] Differences in fluidity and viscosity of brand-name and generic injectable ointment
    Ishimura, Atsushi
    Ogawa, Chiaki
    Yatabe, Megumi
    Tani, Kentaro
    Inoue, Motoki
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2024, 18 (04): : 265 - 268
  • [46] Continuing trends in US brand-name and generic drug competition
    Grabowski, Henry
    Long, Genia
    Mortimer, Richard
    Bilginsoy, Mehmet
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 908 - 917
  • [47] Response of Behcet's syndrome to brand-name but not generic tetracycline
    Cohen, JB
    Bergstresser, PR
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1997, 22 (03) : 159 - 160
  • [48] "Real World" Difference in Effectiveness between Brand-Name and Generic Drugs - Real? or Fantasy?
    Wu, Yih-Jer
    [J]. INTERNATIONAL JOURNAL OF GERONTOLOGY, 2019, 13 (02) : 105 - 105
  • [49] Brand-name buildup
    Rutledge, J
    [J]. FORBES, 1997, 160 (12): : 72 - 72
  • [50] Evolving Brand-Name And Generic Drug Competition May Warrant A Revision Of The Hatch-Waxman Act
    Grabowski, Henry G.
    Kyle, Margaret
    Mortimer, Richard
    Long, Genia
    Kirson, Noam
    [J]. HEALTH AFFAIRS, 2011, 30 (11) : 2157 - 2166